🇺🇸 FDA
Patent

US 9643967

Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 9643967 (Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/00, A61P1/04, A61P17/00, A61P17/06